A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients
Clinical trial NCT03502681 · TERMINATED
Trial details
- NCT number
- NCT03502681
- Sponsor
- Monika Joshi, MD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2019-10-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.